期刊文献+

螺内酯对大鼠主动脉粥样硬化斑块内血管紧张肽转化酶2表达作用的实验研究

Experimental study about spirolactone effects angiotensin - converting enzyme 2 express in the aorta atherosclerosis plaque of mice
下载PDF
导出
摘要 目的研究螺内酯对Wistar大鼠主动脉粥样硬化斑块及斑块内血管紧张肽转化酶2(ACE2)表达的影响。方法雄性Wistar大鼠30只随机分三组:螺内酯组、生理盐水组和空白对照组。采用高脂饮食加大剂量维生素D,腹腔注射法制备大鼠主动脉粥样硬化斑块模型。喂养50mg/(kg·d)螺内酯42d后取主动脉,苏丹Ⅳ染色确定主动脉粥样硬化斑块,病理切片观察动脉粥样硬化斑块,细胞原位杂交技术(ISH)观察斑块内ACE2mRNA表达。结果螺内酯组动脉粥样硬化斑块占主动脉内膜比率显著低于生理盐水组(螺内酯20.1%,生理盐水组33.8%,P〈0.0t)。螺内酯组主动脉粥样硬化斑块纤维帽厚度显著大于生理盐水组(螺内酯组27.3μm,生理盐水组6.3μm,P〈0.01),斑块内脂质池厚度小于生理盐水组(螺内酯组27.5μm,生理盐水组38.8μm,P〈0.05)。40倍视野下泡沫细胞数螺内酯组低于生理盐水组(螺内酯组16.5个/视野,生理盐水组43.2个/视野,P〈0.01)。螺内酯组斑块内ACE2表达高于对照组。结论螺内酯能延缓大鼠主动脉粥样硬化斑块进展并增加斑块稳定性及主动脉粥样硬化斑块内ACE2表达。 Objective To study the effect of spirolactone on mice aortic atherosclerosis plaque and ACE2 express in the plaque. Methods Thirty male wistar mice were randomly divided into three groups: spirolactone group, saline group and control group. Establishing rat aortic atherosclerosis model using large amount vitamin D3 intraperitoneal injection and high cholesterol diet. Decollement aorta after feed the mice with spirolactone 50 mg/( kg·d) for 42 days, the aorta was stained with Sudan IV to observe the atherosclerosis plaque. Pathological slice to observe the atherosclerosis plaque. In situ hybridization( ISH ) to observe ACE2 mRNA express in the plaque. Results The percentage of atherosclerosis plaque in the aorta intima area of spirolactone group was obviously less than the saline group(20.1% vs 33.8, P 〈 0. 01 ). In spirolactone group , the fibrous cap of the atherosclerosis plaque was thicker than the saline group(27.3μm vs 6.3 μm, P 〈 0. 01 ) while the lipid pool was thinner than the saline group(27.5 vs 38.8, P 〈0.05). The spirolactone group had more foam cells than the saline group in the 40 x microscope view( 16.5/FN vs 43.2/FN, P 〈0.01 ). The ACE2 express in the plaque of spirolactone group was more than saline group. Conclusion Spirolactone can obviously improve the mice aorta atherosclerosis plaque and increase the stabilization of the plaque, and it can also increase the ACE2 expression in the aortic atherosclerosis plaque.
出处 《中国急救医学》 CAS CSCD 北大核心 2011年第12期1075-1078,I0011,共5页 Chinese Journal of Critical Care Medicine
关键词 螺内酯 动脉粥样硬化斑块 血管紧张肽转化酶2(ACE2) Spirolactone Atherosclerosis ACE2
  • 相关文献

参考文献14

  • 1Chappel MC, Ferrario CM. ACE and ACE2 : their role to balance the expression of Ang I otensin II and Ang I otensin - ( 1 - 7 ) [ J ]. Kidney Int, 2006, 70(1) : 8 - 10.
  • 2赵巍,郑杨,佟倩.血管紧张素转换酶2的研究进展[J].中华急诊医学杂志,2006,15(5):476-478. 被引量:2
  • 3Chappell MC. Emerging evidence for a functional Ang I otensin - converting enzyme 2 - Ang I otensin - ( 1 - 7 ) - Mas receptor axis : more than regulation of blood pressure [ J ]. Hypertension, 2007, 50 (4) : 596 -599.
  • 4Crackower MA, Sarao R, Oudit GY, et al. Ang I otensin - converting enzyme 2 is an essential regulator of heart function[ J]. Nature, 2002, 417(6891 ) : 822 -828.
  • 5周燕,王晋明,梁远红,王芳.缬沙坦、螺内酯及其联用对逆转自发性高血压大鼠心肌重塑的影响[J].中华急诊医学杂志,2005,14(1):35-38. 被引量:7
  • 6Virdis A, Neves MF, Amiri F, et al. Spironolactone improves angiotensin - induced vascular changes and oxidative stress[ J ]. Hypertension, 2002, 40(4) : 504 -510.
  • 7Zulli A, Burrell LM, Widdop RE, et al. Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic laques[ J]. J Histochem Cytochem, 2006, 54(2) : 147 -150.
  • 8Igase M, Strawn WB, Gallagher PE, et al. Ang I otensin II AT1 receptors regulate ACE2 and Ang I otensin - ( 1 - 7 ) expression in the aorta of spontaneously hypertensive rats[J]. Am J Physiol Heart Circ. Physiol, 2005, 289(3) : H1013 - 1019.
  • 9温进坤,韩梅,杜玮南,高社军.一种快速建立大鼠动脉粥样硬化模型的实验方法[J].中国老年学杂志,2001,21(1):50-52. 被引量:109
  • 10Sibony M, Commo F, Callard P, et al. Enhancement of mRNA in situ hybridization signal by microwave heating [ J ]. Lablnvest, 1995, 73(4) : 586 -591.

二级参考文献35

  • 1孙琰,柳林,潘欣.SARS冠状病毒S蛋白的功能性受体-ACE2[J].微生物学杂志,2004,24(4):25-30. 被引量:5
  • 2孙琰,潘欣,柳林,倪灿荣.SARS-CoVS蛋白功能性受体ACE2在人、兔角膜、结膜中的表达[J].眼科新进展,2004,24(5):332-336. 被引量:26
  • 3吴淑梅 梅美珍 等.实验性动脉粥样硬化病理模型的复制.动脉粥样硬化实验技术[M].中国病理生理学会动脉粥样硬化专业委员会,1989.1-10.
  • 4Bader M. Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models. J Mol Cell Cardiol,2002, 34: 1455-1462.
  • 5Baursachs J, Fraccarollo D. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure. Minerva Cardio angiol, 2003, 51: 155-164.
  • 6Lakkis J, Lu WX, Weir MR. RAAS Escape: A real clinical entity that may be important in the progression of cardiovascular and renal disease.Curr Hypertens Rep, 2003, 5: 4008-4017.
  • 7Varagic J, Frohlich ED. Local cardiac renin-angiotensin system: hypertension and cardiac failure. J Mol Cell Cardiol, 2002, 34: 1435-1442.
  • 8Silvestre JS, Robert V, Heymes C, et al. Myocardial production of aidosterone and corticosterone in the rat. Physiological Regulation J Biol Chem, 1998, 273: 4883-489.
  • 9Lopes ME, Le Corvoisier P, Tabet JY, et al. Aldosterone and its antagonists in heart failure. Presse Med, 2003, 32: 79-87.
  • 10Pitt B, Zannad F, Remme W J, el at. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med, 1999, 341:709-717.

共引文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部